{"type":"rich","title":"Ezetimibe and PCSK-9 Inhibitors \u2013 Cholesterol Test Prep and Practice Pearls","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"Real Life Pharmacology - Pharmacology Education for Health Care Professionals","html":"<iframe src=\"https://player.blubrry.com/?podcast_id=152062553\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"In this pharmacology podcast episode, we focus on two key non-statin cholesterol-lowering therapies: ezetimibe and PCSK9 inhibitors (Click here to listen to the statin podcast episode). These agents play a role in lipid management, particularly for patien","thumbnail_url":"https://assets.blubrry.com/coverart/160/542381.jpg"}